Cardiologists are more willing to prescribe β-blockers than respiratory physicians: An Australasian clinical scenario survey

Internal Medicine Journal

Volumn 43, Issue 5, 2013, Pages 507-512

  Jones, T E ^a   Ruffin, R E ^b   Arstall, M ^c  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c LYELL MCEWIN HOSPITAL   (Australia)

Author keywords

blocker; Cardiologist; Heart failure; Respirologist; Survey

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; BRONCHOSPASM; CARDIOLOGIST; HEALTH CARE SURVEY; HUMAN; MEDICAL SOCIETY; MEDICAL SPECIALIST; PRESCRIPTION; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; AUSTRALASIA; CARDIOLOGY; CHOICE BEHAVIOR; DATA COLLECTION; DRUG PRESCRIPTIONS; HUMANS; PHYSICIANS; PULMONARY MEDICINE;

EID: 84877905601     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12035     Document Type: Article

References (24)

1. Everly M, Heaton PC, Cluxton RJ. β-blocker underuse in secondary prevention of myocardial infarction. Ann Pharmacother 2004; 38: 286-293.
2. Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective β-blockers in patients with reactive airways disease: a meta-analysis. Ann Int Med 2002; 137: 715-725.
3. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998; 339: 489-497.
4. Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB. Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 2008; 63: 301-305.
5. Egred M, Shaw S, Mohammad B, Waitt P, Rodrigues E. Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease. Q J Med 2005; 98: 493-497.
6. Olenchock BA, Fonarow GG, Pan W, Hernandez A, Cannon CP, for the Get with the Guidelines Steering Committee. Current use of beta blockers in patients with reactive airways disease who are hospitalised with acute coronary syndromes. Am J Cardiol 2009; 103: 295-300.
7. Short PM, Lipworth SIW, Elder DHJ, Schembri S, Lipworth BJ. Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ 2001; 342: d2549.
8. Rutten FH, Zuithoff NPA, Hak E, Grobbee DE, Hoes AW. β-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. Arch Intern Med 2010; 170: 880-897.
9. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. JAMA 2001; 37: 1950-1956.
10. McNeil RS. Effect of a β-adrenergic-blocking agent, propranolol, on asthmatics. Lancet 1964; 2: 1101-1102.
11. Harries AD. Beta blockade in asthma. Br Med J 1981; 282: 1321.
12. Williams IP, Millard FJC. Severe asthma after inadvertent ingestion of oxprenolol. Thorax 1980; 35: 160.
13. van der Woude HJ, Zaagsma J, Postma DS, Winter TH, van Hulst M, Aalbers R. Detrimental effects of β-blockers in COPD - a concern for nonselective β-blockers. Chest 2005; 127: 818-824.
14. Chaterjee SS. Letter to the Editor. BMJ 1981; 282: 1322.
15. Lipworth BJ, Brown RA, McDevitt DG. Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoreceptor blockade. Brit J Clin Pharmacol 1989; 28: 95-102.
16. Lipworth BJ, Irvine NA, McDevitt DG. The effects of time and dose on the relative β1 and β2-adrenoreceptor antagonism of betaxolol and atenolol. Br J Clin Pharmacol 1991; 31: 154-159.
17. Dulin B, Krum H. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence. Curr Opin Cardiol 2006; 21: 393-399.
18. Sadiq SA, Fielding K, Vernon SA. The effect of timolol drops on respiratory function. Eye 1998; 12: 386-389.
19. Hepsen IF, Yildirim Z, Yilmaz H, Kotuk M. Preventive effect of lacrimal occlusion on topical timolol-induced bronchoconstriction in asthmatics. Clin Experiment Ophthalmol 2004; 32: 597-602.
20. Fraunfelder FT, Barker AF. Respiratory effects of timolol. N Engl J Med 1984; 311: 1441.
21. Jones Terry E, Southcott AM, Homan S. The extent of airways reversibility on pulmonary function testing is frequently compromised by prescribed drugs. Respirology 2010; 15: A57.
22. Jarrod I, Morrell J, Huntley K, Eiser N. An on-line survey of clinicians on distinguishing between COPD and asthma. Abstract E4561, European Respiratory Society Conference, Vienna 2009.
23. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64: 728-735.
24. Short PM, Williamson PA, Lipworth BJ. Effects of hydrocortisone on acute beta-blocker and histamine induced bronchoconstriction. Br J Clin Pharmacol 2012; 73: 717-726.